BioSpace News Archive

Transparency Market Research has published a new report titled, “Foot Orthotic Insoles Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global foot orthotic insoles market was valued at US$ 3,176.4 Mn in 2017 and is projected to expand at a CAGR of 6.3% from 2018 to 2026.

Transparency Market Research has published a new report titled “Cardiac Biomarker Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.” According to the report, the global cardiac biomarker diagnostic kits market was valued at US$ 2,100 Bn in 2017.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a closely held biotechnology company, today announced that the companies have entered into a collaboration agreement to develop EIDD-2801, an orally available antiviral candidate currently in early clinical develop

- Robust Response Sustained through Two Years of Treatment with Zygel™ in Patients from Phase 2 FAB-C Trial - - Top Line Results of Pivotal CONNECT-FX Trial Expected Late in the Second Quarter of 2020 -

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced the appointment of Dr. Charles Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development, effective immediately.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced that Nancy Lurker, President and Chief Executive Officer, is scheduled to present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 8:30 AM ET.

Matinas BioPharma Holdings, Inc., announced that Jerome D. Jabbour, Chief Executive Officer, has been invited to present a company overview during the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 8:00 a.m. ET.

Oncolytics Biotech® Inc., currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, announced the publication of an electronic-poster with clinical data from the Company’s AWARE-1 window-of-opportunity breast cancer study.

SMART’s G-EYE® Colonoscope, incorporating the G-EYE® Balloon Technology which helps control the endoscope’s field of view and positioning during colonoscopy, was cleared for marketing in the USA by FDA

Vanda Pharmaceuticals Inc., announced that Vanda will hold its 2020 Annual Meeting of Stockholders in a virtual-only format due to public health concerns related to the COVID-19 pandemic and to protect the health and well-being of its stockholders, directors, employees and the public.